André Muller

André Muller graduated from the EM Lyon Business school. He brings to the board his extensive experience in the healthcare sector as CFO, director and investor.

André Muller, among others, served as Deputy Managing Director in charge of Finance at Actélion, a Swiss biotechnology company, which was acquired in 2017 by the American pharmaceutical group Johnson & Johnson.

He also contributed to the foundation of Idorsia Ltd, which he led to an IPO. The company is a spin-off of Actélion’s clinical research and development business.